GDRX240517P5000
- 0.10
- 0.000.00%
GoodRx Newsroom
NVIDIA, Dell Technologies, Super Micro Computer Among Premarket Gainers' Pack
Wells Fargo Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Wells Fargo analyst Stan Berenshteyn maintains $GoodRx(GDRX.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 58.8% and a tota
Express News | GoodRx Holdings Shares Are Trading Higher After RBC Capital Upgraded the Stock From Sector Perform to Outperform
BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Maintains Target Price $5
BofA Securities analyst Allen Lutz maintains $GoodRx(GDRX.US)$ with a sell rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 52.5% and a total
GoodRx Holdings Sell Rating: Navigating Strategic Shifts and Industry Trends
RBC Capital Upgrades GoodRx(GDRX.US) to Buy Rating, Raises Target Price to $10
RBC Capital analyst Sean Dodge upgrades $GoodRx(GDRX.US)$ to a buy rating, and adjusts the target price from $8 to $10.According to TipRanks data, the analyst has a success rate of 38.5% and a total a
Express News | GoodRx Holdings Inc : RBC Raises to Outperform From Sector Perform; Raises Target Price to $10 From $8
GoodRx Holdings Is Maintained at Overweight by Barclays
GoodRx Holdings Is Maintained at Overweight by Barclays
Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)
Express News | GoodRx Holdings Inc. : Barclays Raises Target Price to $10 From $9
Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO), GoodRx Holdings (GDRX) and NewAmsterdam Pharma Company (NAMS)
GoodRx Shares Are Trading Lower, Pulling Back After Rising in Recent Sessions on a Deal With Kroger.
GoodRx Shares Are Trading Lower, Pulling Back After Rising in Recent Sessions on a Deal With Kroger.
UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating
GoodRx Holdings (GDRX) has an average outperform rating and a price target range of $5 to $16, according to analysts polled by Capital IQ. Price: 8.16, Change: +0.09, Percent Change: +1.18
Express News | GoodRx Holdings Inc : Deutsche Bank Raises Target Price to $9 From $8
All Time Highs Came and Went | Wall Street Today
The market simmered from all-time highs Thursday morning to close lower with 7000 decliners compared to 5900 advancing equities. Still, the
GoodRx Holdings Price Target Announced at $10.00/Share by Raymond James
GoodRx Holdings Price Target Announced at $10.00/Share by Raymond James
GoodRx Shares Rise After Raymond James Upgrade
GoodRx Holdings rose more than 12% in recent Thursday trading after Raymond James upgraded the company's stock to outperform from market perform. Trading volume was around 2.6 million shares ag
GoodRx Rallies for Second Day Amid Kroger Deal, Analyst Upgrade
Express News | GoodRx Holdings Shares Are Trading Higher After the Company on Wednesday Announced That It Signed a New Direct Contracting Agreement With Kroger. TD Cowen Raised Its Price Target on the Stock Form $14 to $16
Forecasting The Future: 13 Analyst Projections For GoodRx Holdings
In the latest quarter, 13 analysts provided ratings for GoodRx Holdings (NASDAQ:GDRX), showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offer